March 9, 2020 / 12:22 PM / 3 months ago

BRIEF-U.S. FDA Accepts Biologics License Application For Mylan And Biocon's Proposed Biosimilar Bevacizumab For Review

March 9 (Reuters) -

* U.S. FDA ACCEPTS BIOLOGICS LICENSE APPLICATION (BLA) FOR MYLAN AND BIOCON’S PROPOSED BIOSIMILAR BEVACIZUMAB FOR REVIEW Source text for Eikon:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below